MYCELX Technologies Corporation
MYX.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.04 | 0.00 | 0.09 | -0.06 |
| FCF Yield | -6.95% | -15.44% | -3.33% | -5.53% |
| EV / EBITDA | -4.87 | -4.58 | -8.87 | -11.72 |
| Quality | ||||
| ROIC | -46.54% | -37.75% | -31.23% | -27.29% |
| Gross Margin | 41.68% | 25.52% | 28.17% | 25.72% |
| Cash Conversion Ratio | 0.32 | 1.18 | 0.40 | 0.46 |
| Growth | ||||
| Revenue 3-Year CAGR | -5.49% | -5.96% | -10.74% | -18.63% |
| Free Cash Flow Growth | 61.46% | -175.09% | 41.97% | -396.53% |
| Safety | ||||
| Net Debt / EBITDA | -0.22 | 0.00 | 0.38 | -0.32 |
| Interest Coverage | -413.60 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.18 | 0.26 | 0.93 | 1.16 |
| Cash Conversion Cycle | 452.24 | 434.23 | 95.45 | 77.42 |